Palouse Capital Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Hold
1,223
0.09% 85
2026
Q1
$115K Hold
1,223
0.08% 87
2025
Q4
$121K Sell
1,223
-16,800
-93% -$1.63M 0.08% 84
2025
Q3
$1.53M Sell
18,023
-65
-0.4% -$5.14K 0.97% 47
2025
Q2
$1.23M Buy
18,088
+5
+0% +$317 0.81% 51
2025
Q1
$1.09M Sell
18,083
-799
-4% -$55.7K 0.75% 51
2024
Q4
$1.3M Sell
18,882
-219
-1% -$15.6K 0.87% 47
2024
Q3
$1.26M Sell
19,101
-509
-3% -$32.5K 0.8% 49
2024
Q2
$1.19M Sell
19,610
-313
-2% -$17.7K 0.8% 50
2024
Q1
$1.14M Buy
+19,923
New +$1.2M 0.75% 53

Other funds holding INCY

Palouse Capital Management's INCY Position: Q2 2026 in Review

Palouse Capital Management held its Incyte (INCY) position steady in Q2 2026 at 1,223 shares worth $139K. The position accounts for 0.09% of the portfolio, ranked #85.

Palouse Capital Management first reported a position in INCY in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.53M in Q3 2025. 134 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Palouse Capital Management held 1,223 shares of Incyte worth $139K as of Q2 2026.
  • Palouse Capital Management left its Incyte share count unchanged in Q2 2026.
  • Incyte made up 0.09% of Palouse Capital Management's portfolio in Q2 2026, its #85 holding.
  • Palouse Capital Management first reported a position in Incyte in Q1 2024 and has held it in 10 quarters since.
  • Palouse Capital Management's Incyte position peaked at $1.53M in Q3 2025.
  • 134 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.